Dimensional Fund Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-48,663
| Closed | -$109K | – | 3396 |
|
|
2024
Q2 | $109K | Sell |
48,663
-6,437
| -12% | -$14.5K | ﹤0.01% | 3241 |
|
|
2024
Q1 | $122K | Buy |
+55,100
| New | +$122K | ﹤0.01% | 3241 |
|
|
2022
Q3 | – | Sell |
-45,082
| Closed | -$69K | – | 3532 |
|
|
2022
Q2 | $69K | Buy |
45,082
+5,688
| +14% | +$8.71K | ﹤0.01% | 3369 |
|
|
2022
Q1 | $101K | Sell |
39,394
-30,478
| -44% | -$78.1K | ﹤0.01% | 3393 |
|
|
2021
Q4 | $204K | Buy |
69,872
+21,402
| +44% | +$62.5K | ﹤0.01% | 3338 |
|
|
2021
Q3 | $119K | Sell |
48,470
-31,717
| -40% | -$77.9K | ﹤0.01% | 3410 |
|
|
2021
Q2 | $326K | Buy |
+80,187
| New | +$326K | ﹤0.01% | 3247 |
|